The European Union has approved a French company’s artificial heart to be sold to EU hospitals as a short term solution for those waiting for heart transplants.
The European Union has approved a French company’s artificial heart to be sold to EU hospitals as a short term solution for those waiting for heart transplants.
Artificial heartmaker Carmat will begin sales of its devices from the second quarter of this year after a long-awaited European..